TSXV:WRLG
TSXV:WRLGMetals and Mining

West Red Lake Gold Mines (TSXV:WRLG) Valuation After Madsen Gold Mine Reaches Commercial Production

West Red Lake Gold Mines (TSXV:WRLG) has drawn fresh attention after announcing that its 100% owned Madsen Gold Mine reached commercial production on January 1, 2026, supported by steady mill throughput and recoveries. See our latest analysis for West Red Lake Gold Mines. The commercial production news at Madsen comes after a strong run in the shares, with a 24.27% year to date share price return and a very large 312.90% three year total shareholder return. This suggests momentum has been...
NasdaqGS:UFPI
NasdaqGS:UFPIBuilding

Should UFPI’s Sliding EPS and Returns on Capital Require Action From UFP Industries (UFPI) Investors?

UFP Industries recently reported that unit sales have fallen over the past two years, with earnings per share dropping faster than revenue and returns on capital slipping, pointing to past profit pools becoming harder to sustain. This combination of weaker volumes, compressed earnings, and declining capital efficiency raises fresh questions about how durable the company’s profit engine may be. Next, we’ll examine how the ongoing slide in earnings per share shapes UFP Industries’ investment...
NYSE:BANC
NYSE:BANCBanks

Assessing Banc Of California (BANC) Valuation As Q4 Earnings Arrival Nears

What Banc of California’s upcoming earnings mean for shareholders Banc of California (BANC) reports its Q4 2025 results after the market closes today, and this earnings release is in focus after recent quarters where the bank outpaced revenue and earnings expectations. Analysts are looking for Q4 revenue growth of 9.2% year on year and adjusted earnings of $0.37 per share, so tonight’s update will show how the bank is tracking against those expectations. See our latest analysis for Banc of...
NYSE:MTN
NYSE:MTNHospitality

How Investors May Respond To Vail Resorts (MTN) Near‑Record Low Snowpack And Weaker Skier Visits

Vail Resorts recently reported that Vail Mountain’s snowpack hit its lowest level in 47 years, with snowfall in the Rockies down sharply versus long‑term averages, limiting terrain openings and reducing skier visits earlier this season. Beyond immediate operational pressures, the snow drought has intensified concerns about regional water supplies and highlighted how weather variability can affect both resort performance and local communities. We’ll now examine how these historically poor...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

Kyivstar’s Lviv 5G Pilot Might Change The Case For Investing In VEON (VEON)

VEON’s Ukrainian subsidiary Kyivstar has already launched a 5G test zone in the historical center of Lviv, working with the Ministry of Digital Transformation to assess real-world network performance and prepare for potential future expansion to other major cities once conditions allow. This pilot underlines how VEON is upgrading Ukraine’s digital infrastructure even during wartime, while still prioritizing broad 4G coverage that currently serves most smartphone users’ needs. We’ll now look...
NYSE:J
NYSE:JProfessional Services

Jacobs Solutions (J) Valuation Check After Securing Key Sizewell C Nuclear Project Role

Jacobs Solutions (J) has been selected by Sizewell C for a five year Professional Services Framework on a new nuclear power station in Suffolk, England, placing the company at the center of a major low carbon energy project. See our latest analysis for Jacobs Solutions. Despite landing several sizeable contracts across nuclear, water infrastructure and high performance computing in January, Jacobs’ recent share price return has been mixed, with a 1 day decline of 2.65%, a 90 day share price...
OM:TFBANK
OM:TFBANKBanks

TF Bank (OM:TFBANK) Is Up 6.7% After Strong 2025 Earnings And SEK 5 Dividend Proposal – Has The Bull Case Changed?

In January 2026, TF Bank AB (publ) reported full-year 2025 results showing higher net interest income of SEK 2,678.96 million and net income of SEK 667.05 million, alongside basic and diluted earnings per share of SEK 9.92. The Board also proposed a dividend of SEK 5.00 per share for 2025, signaling confidence in the bank’s ability to return capital to shareholders from its recent performance. With this combination of rising earnings and a proposed SEK 5.00 dividend, we’ll examine how TF...
NYSE:DAN
NYSE:DANAuto Components

Assessing Dana (DAN) Valuation After High End 2025 Guidance And Profitability Focus

What triggered the latest interest in Dana (DAN)? Dana (DAN) is back on investors’ radar after the company issued 2025 sales guidance of US$7.30b to US$7.70b, alongside preliminary 2025 results that landed at the high end of its own expectations. See our latest analysis for Dana. That guidance and the focus on profitability and balance sheet repair arrive after a strong run in the stock, with a 90 day share price return of 38.54% and a 1 year total shareholder return of 104.87%. This comes...
OB:DNO
OB:DNOOil and Gas

How Strong North Sea Sales and New Finds Will Impact DNO (OB:DNO) Investors

DNO ASA has released its fourth-quarter 2025 operating update, reporting higher gross and net entitlement production alongside sharply increased sales volumes from both Kurdistan and the North Sea compared with a year earlier. Beyond the production uplift, the quarter also saw two potentially commercial oil discoveries on the Norwegian Continental Shelf, which may offer future tie-back opportunities to existing infrastructure. Next, we will explore how this strong uplift in North Sea sales...
TSX:VZLA
TSX:VZLAMetals and Mining

Assessing Vizsla Silver (TSX:VZLA) Valuation After Major Panuco Resource Upgrade And Construction Progress

Vizsla Silver (TSX:VZLA) shares were in focus after the company released a year-end update on its Panuco silver gold project, highlighting a 43% rise in measured and indicated resources and progress toward construction. See our latest analysis for Vizsla Silver. The year-end Panuco update lands after a strong run in Vizsla Silver's shares, with a 22.33% 1 month share price return and a 58.32% 3 month share price return. The 1 year total shareholder return is very large and momentum looks to...
NasdaqGS:DCOM
NasdaqGS:DCOMBanks

Assessing Dime Community Bancshares (DCOM) Valuation After Strong 2025 Earnings And Improved Credit Trends

Why Dime Community Bancshares is back on investor radars Dime Community Bancshares (DCOM) just posted full year 2025 results, reporting net interest income of US$408 million and net income of US$110.68 million, alongside lower quarterly net loan charge offs compared with last year. See our latest analysis for Dime Community Bancshares. The latest full year figures and improvement in net loan charge offs have arrived after a mixed stretch for the stock, with a 1 day share price return of 2.56%...
SGX:N2IU
SGX:N2IUREITs

A Look At Mapletree Pan Asia Commercial Trust (SGX:N2IU) Valuation After The HarbourFront District Cooling Collaboration

Mapletree Pan Asia Commercial Trust (SGX:N2IU) is drawing fresh attention after partnering with SP Group to roll out a shared district cooling system across five HarbourFront properties in Singapore, targeting improvements in energy, cost and emissions efficiency. See our latest analysis for Mapletree Pan Asia Commercial Trust. Despite the news around the HarbourFront district cooling project, Mapletree Pan Asia Commercial Trust’s recent share price moves have been muted, with a small 30 day...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Why Precigen (PGEN) Is Up 5.3% After PAPZIMEOS Becomes First-Line RRP Standard of Care – And What's Next

Precigen, Inc. recently announced that an expert consensus paper in The Laryngoscope, sponsored by the Recurrent Respiratory Papillomatosis Foundation and authored by 16 leading physicians, recommends PAPZIMEOS (zopapogene imadenovec) as the new first-line standard of care for adults with recurrent respiratory papillomatosis. This independently authored guidance marks a pivotal shift away from repeated surgical procedures toward an FDA-approved HPV-specific immunotherapy that targets the...
NYSE:PWR
NYSE:PWRConstruction

Assessing Quanta Services (PWR) Valuation After New Grid Contracts And Record Project Backlog

Quanta Services (PWR) is back in focus after new grid modernization and energy transition contracts helped push its project backlog to a record level, just as investors look ahead to the upcoming Q4 2025 earnings release. See our latest analysis for Quanta Services. The recent contract wins, record backlog and expectations for the upcoming Q4 2025 results come on top of a multi month rally, with a 30 day share price return of 8.63% and a 1 year total shareholder return of 29.61%. This...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

How Investors May Respond To Zions (ZION) Earnings Beat And Expanding Net Interest Margin

Zions Bancorporation, National Association reported past fourth-quarter 2025 earnings with net interest income of US$683 million and net income of US$263 million, lifting diluted EPS from continuing operations to US$1.76 versus US$1.34 a year earlier. For 2025 as a whole, the bank’s net income rose to US$899 million and diluted EPS to US$6.01, alongside expanding net interest margin, strong deposit growth, and stable credit quality that collectively strengthened its capital position. We’ll...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

A Look At Perella Weinberg Partners (PWP) Valuation After Board Leadership Transition News

Perella Weinberg Partners (PWP) is in focus after announcing a board leadership transition, with founder Peter A. Weinberg set to step down as Chairman and CEO Andrew Bednar preparing to assume the Chairman role. See our latest analysis for Perella Weinberg Partners. The leadership transition news comes as Perella Weinberg Partners’ share price has moved to US$21.60, with a 30 day share price return of 24.14% and a 3 year total shareholder return of 129.20%. This suggests longer term...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Pharmaceuticals (CRVS) Is Up 229.4% After Strong Soquelitinib Data In Tough Dermatitis Patients

Corvus Pharmaceuticals recently reported positive results from cohort 4 of its randomized, blinded, placebo-controlled Phase 1 trial of oral soquelitinib in moderate to severe atopic dermatitis, and confirmed plans to start a Phase 2 study in the first quarter of 2026. The cohort 4 data are particularly interesting because they show clinical activity in patients who had previously failed systemic treatments, including dupilumab and JAK inhibitors, while maintaining a favorable safety profile...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

The Bull Case For uniQure (QURE) Could Change Following FDA Pushback On AMT-130 Evidence Standards

In November 2025, uniQure disclosed that the FDA found data from its Phase I/II AMT-130 Huntington’s disease studies insufficient to support a Biologics License Application, and later feedback questioned the adequacy of its external-control dataset for accelerated approval. This setback highlights how emerging regulatory expectations around evidence standards can materially affect the development path of gene therapies even when early efficacy signals appear encouraging. We’ll now examine...
ASX:AMI
ASX:AMIMetals and Mining

How Aurelia’s Federation Ramp-Up and FY26 Guidance Reaffirmation Will Impact Aurelia Metals (ASX:AMI) Investors

Aurelia Metals has released its December 2025 quarterly update and Q2 2026 results, reporting strong multi-metal production, solid cash generation, and reaffirmed FY26 guidance alongside ongoing ramp-up at the Federation Mine and expansions at Great Cobar and Peak. An interesting angle for investors is how the ahead-of-plan Federation ramp-up and promising Nymagee and Federation drilling results may underpin future capacity growth and resource potential. We’ll now explore how Aurelia Metals’...
NYSE:PKG
NYSE:PKGPackaging

How PKG’s Shift Toward Cost Efficiency and Shareholder Returns Will Impact Packaging Corporation of America (PKG) Investors

In recent months, Packaging Corporation of America has benefited from growing optimism about a recovery in the packaging cycle, supported by disciplined containerboard pricing and management’s focus on high-return mill investments. What stands out is the company’s decision to emphasize cost efficiency and cash returns to shareholders instead of pursuing large acquisitions, signaling a measured approach to capital allocation. Next, we’ll examine how this emphasis on disciplined pricing...
NYSE:ETR
NYSE:ETRElectric Utilities

A Look At Entergy (ETR) Valuation As Analysts Turn More Positive On EPS Growth Prospects

Entergy (ETR) is back in focus after several Wall Street firms reiterated or upgraded their views, pointing to expectations for sustained EPS growth supported by industrial and data center demand and constructive regulation. See our latest analysis for Entergy. At a share price of US$94.75, Entergy’s recent 30 day share price return of 3.55% contrasts with a softer 90 day share price return of a 1.30% decline. A 1 year total shareholder return of 16.51% sits alongside very strong 3 and 5 year...
SWX:GALD
SWX:GALDPharmaceuticals

Assessing Galderma Group (SWX:GALD) Valuation As New Neuromodulator Data Reinforces Relfydess And Dysport

Galderma Group (SWX:GALD) is back in focus after announcing fresh clinical and real world data for its neuromodulators Relfydess and Dysport at the TOXINS 2026 International Conference in Madrid. See our latest analysis for Galderma Group. The fresh neuromodulator data arrives after a softer near term patch for the stock, with a 30 day share price return of 5.53% and a 7 day share price return of a 3.21% decline, even though the 90 day share price return is 12.84% and the 1 year total...
NYSE:SUI
NYSE:SUIResidential REITs

Assessing Sun Communities (SUI) Valuation After Recent Flat Multi Year Share Performance

What Sun Communities’ recent performance might be telling investors Sun Communities (SUI) has drawn attention after a recent move that left its shares around $125.99, with total return over the past year at about 5%, and roughly flat performance over the past 3 years. See our latest analysis for Sun Communities. The recent 1 day share price decline of about 3.3% comes after a 30 day share price return of 2.7% and a 1 year total shareholder return of roughly 5%, suggesting only modest momentum...
NYSE:SCI
NYSE:SCIConsumer Services

A Look At Service Corporation International (SCI) Valuation After Earnings Beat And Fresh Analyst Coverage

Service Corporation International (SCI) has been in focus after its latest quarter showed 4.4% year on year revenue growth, topping analyst expectations by 1.5%, while recent positive Wall Street coverage has added another layer of investor attention. See our latest analysis for Service Corporation International. The share price, which closed at $82.35, has had a 5.3% 30 day share price return and a 6.7% year to date share price return. The 5 year total shareholder return of 66.1% points to...